Mesoblast Limited

/s/ Charlie Harrison

Charlie Harrison

Company Secretary

Item

99.1

Press release of Mesoblast Ltd, dated February 20, 2020.

99.2

Appendix 3G of Mesoblast Ltd, dated February 21, 2020.

99.3

Press release of Mesoblast Ltd, dated February 24, 2020

Mesoblast Limited
ABN 68 109 431 870

www.mesoblast.com

Corporate Headquarters

Level 38

55 Collins Street

Melbourne 3000

Victoria Australia

T +61 3 9639 6036

F +61 3 9639 6030

United States Operations

505 Fifth Avenue

Third Floor

New York, NY 10017

USA

T +1 212 880 2060

F +1 212 880 2061

Asia

21 Biopolis Road

#01-22 Nucleos (South Tower)

SINGAPORE 138567

T +65 6570 0635

F +65 6570 0176

Mesoblast Limited
ABN 68 109 431 870

www.mesoblast.com

Corporate Headquarters

Level 38

55 Collins Street

Melbourne 3000

Victoria Australia

T +61 3 9639 6036

F +61 3 9639 6030

United States Operations

505 Fifth Avenue

Third Floor

New York, NY 10017

USA

T +1 212 880 2060

F +1 212 880 2061

Asia

21 Biopolis Road

#01-22 Nucleos (South Tower)

SINGAPORE 138567

T +65 6570 0635

F +65 6570 0176

This appendix is not available as an online form

Please fill in and submit as a PDF announcement

+Rule 3.10.3A, 3.10.3B, 3.10.3C

Question no

Question

Answer

1.1

*Name of entity

We (the entity here named) give notice of the issue, conversion or payment up of the following unquoted +securities.

MESOBLAST LTD

1.2

*Registration type and number

Please supply your ABN, ARSN, ARBN, ACN or another registration type and number (if you supply another registration type, please specify both the type of registration and the registration number).

ABN 68 109 431 870

1.3

*ASX issuer code

MSB

1.4

*This announcement is

Tick whichever is applicable.

☒ A new announcement

☐ An update/amendment to a previous announcement

☐ A cancellation of a previous announcement

1.4a

*Reason for update

Mandatory only if “Update” ticked in Q1.4 above. A reason must be provided for an update.

N/A

1.4b

*Date of previous announcement to this update

Mandatory only if “Update” ticked in Q1.4 above.

N/A

1.4c

*Reason for cancellation

Mandatory only if “Cancellation” ticked in Q1.4 above.

N/A

1.4d

*Date of previous announcement to this cancellation

Mandatory only if “Cancellation” ticked in Q1.4 above.

N/A

1.5

*Date of this announcement

21 February 2020

+ See chapter 19 for defined terms

31 January 2020

Page 1

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

Question No.

Question

Answer

2.1

*The +securities the subject of this notification are:

Select whichever item is applicable.

If you wish to notify ASX of different types of issues of securities, please complete a separate Appendix 3G for each type of issue.

☐  +Securities issued as a result of options being exercised or other +convertible +securities being converted and that are not to be quoted on ASX

☐  Partly paid +securities that have been fully paid up and that are not to be quoted on ASX

☒  +Securities issued under an +employee incentive scheme that are not being immediately quoted on ASX

☐  Other [please specify]

If you have selected ‘other’ please provide the circumstances of the issue here:

2.2a.1

Please state the number and type of options that were exercised or other +convertible securities that were converted (including their ASX security code if available)?

Answer this question if your response to Q2.1 is “securities issued as a result of options being exercised or other convertible securities being converted and that are not to be quoted on ASX”.

N/A

2.2a.2

And the date the options were exercised or other +convertible securities were converted:

Answer this question if your response to Q2.1 is “securities issued as a result of options being exercised or other convertible securities being converted and that are not to be quoted on ASX”.

Note: If this occurred over a range of dates, enter the date the last of the options was exercised or convertible securities was converted.

N/A

2.2b.1

Please state the number and type of partly paid +securities that were fully paid up (including their ASX security code if available)?

Answer this question if your response to Q2.1 is “partly paid securities that have been paid up and that are not to be quoted on ASX”.

N/A

2.2b.2

And the date the +securities were fully paid up:

Answer this question if your response to Q2.1 is “partly paid securities that have been paid up and that are not to be quoted on ASX”.

Note: If this occurred over a range of dates, enter the date the last of the securities was fully paid up.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 2

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

2.2c.1

Please state the number and type of +securities (including their ASX security code) issued under an +employee incentive scheme that are not being immediately quoted on ASX

Answer this question if your response to Q2.1 is “securities issued under an employee incentive scheme that are not being immediately quoted on ASX”.

5,180,000 unquoted options to acquire ordinary shares, issued pursuant to the Company’s Employee Share Option Plan

2.2c.2

*Please attach a document or provide details of a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms.

Answer this question if your response to Q2.1 is “securities issued under an employee incentive scheme that are not being immediately quoted on ASX”.

Refer to Item 6 in Notice of Meeting released 27 November 2019

https://www.asx.com.au/asxpdf/20191029/pdf/44b06zfvzb0vzb.pdf

2.2c.3

*Are any of these +securities being issued to +key management personnel (KMP) or an +associate

Answer this question if your response to Q2.1 is “securities issued under an employee incentive scheme that are not being immediately quoted on ASX”.

No

2.2c.3.a

*Provide details of the recipients and the number of +securities issued to each of them.

Answer this question if your response to Q2.1 is “securities issued under an employee incentive scheme that are not being immediately quoted on ASX” and your response to Q2.2c.3 is “Yes”. Repeat the detail in the table below for each KMP involved in the issue. If the securities are being issued to the KMP, repeat the name of the KMP or insert “Same” in “Name of registered holder”. If the securities are being issued to an associate of a KMP, insert the name of the associate in “Name of registered holder”.

Name of KMP

Name of registered holder

Number of +securities

2.2d.1

*The purpose(s) for which the entity is issuing the +securities is:

Answer this question if your response to Q2.1 is “Other”.

You may select one or more of the items in the list.

☐  To raise additional working capital

☐  To fund the retirement of debt

☐  To pay for the acquisition of an asset [provide details below]

☐  To pay for services rendered
[provide details below]

☐  Other [provide details below]

Additional details:

2.2d.2

Please provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX, including (if applicable) why the issue of the +securities has not been previously announced to the market in an Appendix 3B

You must answer this question if your response to Q2.1 is “Other”. If there is no other information to provide, please answer “Not applicable” or “N/A”.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 3

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

2.3

*The +securities being issued are:

Tick whichever is applicable

☐  Additional +securities in an existing unquoted class that is already recorded by ASX ("existing class")

☒  New +securities in an unquoted class that is not yet recorded by ASX ("new class")

Part 3A –

number and type of +securities being issued (existing class)

Question No.

Question

Answer

3A.1

*ASX security code & description

N/A

3A.2

*Number of +securities being issued

N/A

3A.3a

*Will the +securities being issued rank equally in all respects from their issue date with the existing issued +securities in that class?

N/A

3A.3b

*Is the actual date from which the +securities will rank equally (non-ranking end date) known?

Answer this question if your response to Q3A.3a is “No”.

N/A

3A.3c

*Provide the actual non-ranking end date

Answer this question if your response to Q3A.3a is “No” and your response to Q3A.3b is “Yes”.

N/A

3A.3d

*Provide the estimated non-ranking end period

Answer this question if your response to Q3A.3a is “No” and your response to Q3A.3b is “No”.

N/A

3A.3e

*Please state the extent to which the +securities do not rank equally:

•in relation to the next dividend, distribution or interest payment; or

•for any other reason

Answer this question if your response to Q3A.3a is “No”.

For example, the securities may not rank at all, or may rank proportionately based on the percentage of the period in question they have been on issue, for the next dividend, distribution or interest payment; or they may not be entitled to participate in some other event, such as an entitlement issue.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 4

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

Question No.

Question

Answer

3B.1

*Security description

4,780,000 unquoted options to acquire ordinary shares at a price per share of A$1.62, vesting in three equal tranches on 20 July 2020, 20 July 2021 and 20 July 2022 respectively, and expiring on 19 July 2026

400,000 unquoted options to acquire ordinary shares at a price per share of A$1.62, vesting in three equal tranches on 28 August 2020, 28 August 2021 and 28 August 2022 respectively, and expiring on 28 August 2026

3B.2

*Security type

Select one item from the list that best describes the securities the subject of this form. This will determine more detailed questions to be asked about the security later in this section. Select “ordinary fully or partly paid shares/units” for stapled securities or CDIs. For interest rate securities, please select the appropriate choice from either “Convertible debt securities” or “Non-convertible debt securities”. Select “Other” for performance shares/units and performance options/rights or if the selections available in the list do not appropriately describe the security being issued.

☐  Ordinary fully or partly paid shares/units

☒  Options

☐  +Convertible debt securities  

☐  Non-convertible +debt securities  

☐  Redeemable preference shares/units

☐  Other

3B.3

ISIN code

Answer this question if you are an entity incorporated outside Australia and you are issuing a new class of securities other than CDIs. See also the note at the top of this form.

N/A

3B.4

*Number of +securities being issued

5,180,000 unquoted options

3B.5a

*Will all the +securities issued in this class rank equally in all respects from the issue date?

Yes

3B.5b

*Is the actual date from which the +securities will rank equally (non-ranking end date) known?

Answer this question if your response to Q3B.5a is “No”.

N/A

3B.5c

*Provide the actual non-ranking end date

Answer this question if your response to Q3B.5a is “No” and your response to Q3B.5b is “Yes”.

N/A

3B.5d

*Provide the estimated non-ranking end period

Answer this question if your response to Q3B.5a is “No” and your response to Q3B.5b is “No”.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 5

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

3B.5e

*Please state the extent to which the +securities do not rank equally:

•in relation to the next dividend, distribution or interest payment; or

•for any other reason

Answer this question if your response to Q3B.5a is “No”.

For example, the securities may not rank at all, or may rank proportionately based on the percentage of the period in question they have been on issue, for the next dividend, distribution or interest payment; or they may not be entitled to participate in some other event, such as an entitlement issue.

N/A

3B.6

Please attach a document or provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued

You may cross reference a disclosure document, PDS, information memorandum, investor presentation or other announcement with this information provided it has been released to the ASX Market Announcements Platform.

Refer to Item 6 in Notice of Meeting released 27 November 2019

https://www.asx.com.au/asxpdf/20191029/pdf/44b06zfvzb0vzb.pdf

3B.7

*Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?

Answer this question only if you are an ASX Listing. (ASX Foreign Exempt Listings and ASX Debt Listings do not have to answer this question).

If your response is “No” and the securities have any unusual terms, you should approach ASX as soon as possible for confirmation under listing rule 6.1 that the terms are appropriate and equitable.

No

3B.8a

Ordinary fully or partly paid shares/units details

Answer the questions in this section if you selected this security type in your response to Question 3B.2.

*+Security currency

This is the currency in which the face amount of an issue is denominated. It will also typically be the currency in which distributions are declared.

N/A

*Will there be CDIs issued over the +securities?

N/A

*CDI ratio

Answer this question if you answered “Yes” to the previous question. This is the ratio at which CDIs can be transmuted into the underlying security (e.g. 4:1 means 4 CDIs represent 1 underlying security whereas 1:4 means 1 CDI represents 4 underlying securities).

N/A

*Is it a partly paid class of +security?

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 6

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

*Paid up amount: unpaid amount

Answer this question if answered “Yes” to the previous question.

The paid up amount represents the amount of application money and/or calls which have been paid on any security considered ‘partly paid’

The unpaid amount represents the unpaid or yet to be called amount on any security considered ‘partly paid’.

The amounts should be provided per the security currency (e.g. if the security currency is AUD, then the paid up and unpaid amount per security in AUD).

N/A

*Is it a stapled +security?

This is a security class that comprises a number of ordinary shares and/or ordinary units issued by separate entities that are stapled together for the purposes of trading.

N/A

3B.8b

Option details

Answer the questions in this section if you selected this security type in your response to Question 3B.2.

*+Security currency

This is the currency in which the exercise price is payable.

AUD

*Exercise price

The price at which each option can be exercised and convert into the underlying security. If there is no exercise price please answer as $0.00.

The exercise price should be provided per the security currency (i.e. if the security currency is AUD, the exercise price should be expressed in AUD).

$1.62

*Expiry date

The date on which the options expire or terminate.

4,780,000 on 19 July 2026

400,000 on 28 August 2026

*Details of the number and type of +security (including its ASX security code if the +security is quoted on or recorded by  ASX) that will be issued if an option is exercised

For example, if the option can be exercised to receive one fully paid ordinary share with ASX security code ABC, please insert “One fully paid ordinary share (ASX:ABC)“.

One fully paid ordinary share (ASX:MSB)

3B.8c

Details of non-convertible +debt securities, +convertible debt securities, or redeemable preference shares/units

Answer the questions in this section if you selected one of these security types in your response to Question 3B.2.

Refer to Guidance Note 34 and the “Guide to the Naming Conventions and Security Descriptions for ASX Quoted Debt and Hybrid Securities” for further information on certain terms used in this section

*Type of +security

Select one item from the list

☐  Simple corporate bond

☐  Non-convertible note or bond

☐   Convertible note or bond

☐  Preference share/unit

☐  Capital note

☐  Hybrid security

☐  Other

*+Security currency

This is the currency in which the face value of the security is denominated. It will also typically be the currency in which interest or distributions are paid.

N/A

Face value

This is the principal amount of each security.

The face value should be provided per the security currency (i.e. if security currency is AUD, then the face value per security in AUD).

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 7

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

*Interest rate type

Select one item from the list

Select the appropriate interest rate type per the terms of the security. Definitions for each type are provided in the Guide to the Naming Conventions and Security Descriptions for ASX Quoted Debt and Hybrid Securities

☐  Fixed rate

☐  Floating rate

☐  Indexed rate

☐  Variable rate

☐  Zero coupon/no interest

☐  Other

Frequency of coupon/interest payments per year

Select one item from the list.

☐  Monthly

☐  Quarterly

☐  Semi-annual

☐  Annual

☐  No coupon/interest payments

☐  Other

First interest payment date

A response is not required if you have selected “No coupon/interest payments” in response to the question above on the frequency of coupon/interest payments

N/A

Interest rate per annum

Answer this question if the interest rate type is fixed.

N/A

*Is the interest rate per annum estimated at this time?

Answer this question if the interest rate type is fixed.

N/A

If the interest rate per annum is estimated, then what is the date for this information to be announced to the market (if known)

Answer this question if the interest rate type is fixed and your response to the previous question is “Yes”.

Answer “Unknown” if the date is not known at this time.

N/A

*Does the interest rate include a reference rate, base rate or market rate (e.g. BBSW or CPI)?

Answer this question if the interest rate type is floating or indexed

N/A

*What is the reference rate, base rate or market rate?

Answer this question if the interest rate type is floating or indexed and your response to the previous question is “Yes”.

N/A

*Does the interest rate include a margin above the reference rate, base rate or market rate?

Answer this question if the interest rate type is floating or indexed.

N/A

*What is the margin above the reference rate, base rate or market rate (expressed as a percent per annum)

Answer this question if the interest rate type is floating or indexed and your response to the previous question is “Yes”.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 8

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

*S128F of the Income Tax Assessment Act status applicable to the +security

Select one item from the list

For financial products which are likely to give rise to a payment to which s128F of the Income Tax Assessment Act applies, ASX requests issuers to confirm the s128F status of the security:

•“s128F exempt” means interest payments are not taxable to non-residents;

•“Not s128F exempt” means interest payments are taxable to non-residents;

•“s128F exemption status unknown” means the issuer is unable to advise the status;

•“Not applicable” means s128F is not applicable to this security

☐  s128F exempt

☐  Not s128F exempt

☐  s128F exemption status unknown

☐  Not applicable

*Is the +security perpetual (i.e. no maturity date)?

N/A

*Maturity date

Answer this question if the security is not perpetual

N/A

*Select other features applicable to the +security

Up to 4 features can be selected. Further information is available in the Guide to the Naming Conventions and Security Descriptions for ASX Quoted Debt and Hybrid Securities.

☐  Simple

☐  Subordinated

☐  Secured

☐  Converting

☐  Convertible

☐  Transformable

☐  Exchangeable

☐  Cumulative

☐  Non-Cumulative

☐  Redeemable

☐  Extendable

☐  Reset

☐  Step-Down

☐  Step-Up

☐  Stapled

☐  None of the above

*Is there a first trigger date on which a right of conversion, redemption, call or put can be exercised (whichever is first)?

N/A

*If yes, what is the first trigger date

Answer this question if your response to the previous question is “Yes”.

N/A

Details of the number and type of +security (including its ASX security code if the +security is quoted on ASX) that will be issued if the securities to be quoted are converted, transformed or exchanged

Answer this question if the security features include “converting”, “convertible”, “transformable” or “exchangeable”.

For example, if the security can be converted into 1,000 fully paid ordinary shares with ASX security code ABC, please insert “1,000 fully paid ordinary shares (ASX:ABC)“.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 9

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

Question No.

Question

Answer

4.1

*Have the +securities been issued yet?

Yes

4.1a

*What was their date of issue?

Answer this question if your response to Q4.1 is “Yes”.

14 February 2020

4.1b

*What is their proposed date of issue?

Answer this question if your response to Q4.1 is “No”.

N/A

4.2

*Are the +securities being issued for a cash consideration?

If the securities are being issued for nil cash consideration, answer this question “No”.

No

4.2a

*In what currency is the cash consideration being paid

For example, if the consideration is being paid in Australian Dollars, state AUD.

Answer this question if your response to Q4.2 is “Yes”.

N/A

4.2b

*What is the issue price per +security

Answer this question if your response to Q4.2 is “Yes” and by reference to the issue currency provided in your response to Q4.2a.

Note: you cannot enter a nil amount here. If the securities are being issued for nil cash consideration, answer Q4.2 as “No” and complete Q4.2c.

N/A

4.2c

Please describe the consideration being provided for the +securities

Answer this question if your response to Q4.2 is “No”.

Securities being issued under the Employee Share Option Plan

4.3

Any other information the entity wishes to provide about the issue

N/A

Following the issue of the +securities the subject of this application, the unquoted issued +securities of the entity will comprise:

Note: the figures provided in the table in section 5.1 below are used to calculate part of the total market capitalisation of the entity published by ASX from time to time. Please make sure you include in the table each class of unquoted securities issued by the entity.

Restricted securities should be included in table 5.1.

5.1

*ASX security code and description

*Total number of +securities on issue

Unquoted options

Incentive rights

29,638,001

1,500,000

+ See chapter 19 for defined terms

31 January 2020

Page 10

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

-

your response to Q2.1 is “+securities issued under an +employee incentive scheme that are not being immediately quoted on ASX”; or

-

your response to Q2.1 is “Other”

Question No.

Question

Answer

6.1

*Are the securities being issued under Listing Rule 7.2 exception 13¹ and therefore the issue does not need any security holder approval under Listing Rule 7.1?

Answer this question if your response to Q2.1 is “securities issued under an employee incentive scheme that are not being immediately quoted on ASX”.

Yes

6.2

*Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1?

Answer this question if the response to Q6.1 is “No”.

N/A

6.2a

*Date of meeting or proposed meeting to approve the issue under listing rule 7.1

Answer this question if the response to Q6.1 is “No” and the response to Q6.2 is “Yes”.

N/A

6.2b

*Are any of the +securities being issued without +security holder approval using the entity’s 15% placement capacity under listing rule 7.1?

Answer this question if the response to Q6.1 is “No” and the response to Q6.2 is “No”.

N/A

¹ Exception 13

An issue of securities under an employee incentive scheme if within 3 years before the issue date:

(a)

in the case of a scheme established before the entity was listed – a summary of the terms of the scheme and the maximum number of equity securities proposed to be issued under the scheme were set out in the prospectus, PDS or information memorandum lodged with ASX under rule 1.1 condition 3; or

(b)

the holders of the entity’s ordinary securities have approved the issue of equity securities under the scheme as an exception to this rule. The notice of meeting must have included:

•

a summary of the terms of the scheme.

•

the number of securities issued under the scheme since the entity was listed or the date of the last approval under this rule;

•

the maximum number of +equity securities proposed to be issued under the scheme following the approval; and

•

a voting exclusion statement.

+ See chapter 19 for defined terms

31 January 2020

Page 11

This appendix is not available as an online form

Appendix 3G

Please fill in and submit as a PDF announcement

Notification of issue, conversion or

payment up of equity +securities

6.2b.1

*How many +securities are being issued without +security holder approval using the entity’s 15% placement capacity under listing rule 7.1?

Answer this question if the response to Q6.1 is “No”, the response to Q6.2 is “No” and the response to Q6.2b is “Yes”.

Please complete and separately send by email to your ASX listings adviser a work sheet in the form of Annexure B to Guidance Note 21 confirming the entity has the available capacity under listing rule 7.1 to issue that number of securities.

N/A

6.2c

*Are any of the +securities being issued without +security holder approval using the entity’s additional 10% placement capacity under listing rule 7.1A (if applicable)?

Answer this question if the response to Q6.1 is “No” and the response to Q6.2 is “No”.

N/A

6.2c.1

*How many +securities are being issued without +security holder approval using the entity’s additional 10% placement capacity under listing rule 7.1A?

Answer this question if the response to Q6.1 is “No”, the response to Q6.2 is “No” and the response to Q6.2c is “Yes”.

Please complete and separately send by email to your ASX listings adviser a work sheet in the form of Annexure C to Guidance Note 21 confirming the entity has the available capacity under listing rule 7.1A to issue that number of securities.

N/A

+ See chapter 19 for defined terms

31 January 2020

Page 12

•

Consistent safety and efficacy were observed across the continuum from first-line treatment after steroid failure through the most challenging patients who received RYONCIL as salvage after exhausting all other options.

•

In the aggregated dataset, 204 of the 309 (66%) patients achieved an overall response at Day 28 following a four-week course of RYONCIL.

•

Results were consistent across all grades of disease, including most severe (IBMTR Grade C/D or Glucksberg Grade 3/4).

•

In the most severe patients (Grade C/D), who accounted for 82% of all treated patients, Day 28 overall response was 65%.

•

Overall response at Day 28 was strongly predictive of survival at Day 100 and Day 180.

•

Day 28 responders were more than twice as likely to survive as non-responders (84% vs 39% at Day 100, and 83% vs 38% at Day 180).

•

RYONCIL was well tolerated with no infusion-related toxicity and no identified safety concerns.

Mesoblast Limited
ABN 68 109 431 870

www.mesoblast.com

Corporate Headquarters

Level 38

55 Collins Street

Melbourne 3000

Victoria Australia

T +61 3 9639 6036

F +61 3 9639 6030

United States Operations

505 Fifth Avenue

Third Floor

New York, NY 10017

USA

T +1 212 880 2060

F +1 212 880 2061

Asia

21 Biopolis Road

#01-22 Nucleos (South Tower)

SINGAPORE 138567

T +65 6570 0635

F +65 6570 0176

Mesoblast Limited
ABN 68 109 431 870

www.mesoblast.com

Corporate Headquarters

Level 38

55 Collins Street

Melbourne 3000

Victoria Australia

T +61 3 9639 6036

F +61 3 9639 6030

United States Operations

505 Fifth Avenue

Third Floor

New York, NY 10017

USA

T +1 212 880 2060

F +1 212 880 2061

Asia

21 Biopolis Road

#01-22 Nucleos (South Tower)

SINGAPORE 138567

T +65 6570 0635

F +65 6570 0176

Mesoblast Limited
ABN 68 109 431 870

www.mesoblast.com

Corporate Headquarters

Level 38

55 Collins Street

Melbourne 3000

Victoria Australia

T +61 3 9639 6036

F +61 3 9639 6030

United States Operations

505 Fifth Avenue

Third Floor

New York, NY 10017

USA

T +1 212 880 2060

F +1 212 880 2061

Asia

21 Biopolis Road

#01-22 Nucleos (South Tower)

SINGAPORE 138567

T +65 6570 0635

F +65 6570 0176